12:00 AM
 | 
Nov 23, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Surfaxin lucinactant regulatory update

Discovery Labs said it submitted a trial protocol to FDA for a proposed study to assess the pharmacodynamics following Surfaxin lucinactant administration in preterm infants with respiratory distress...

Read the full 118 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >